Tech Company Financing Transactions

Perceive Biotherapeutics Funding Round

Braidwell, Catalio Capital Management and Deerfield Management Company joined a $15 million Series A funding round for Perceive Biotherapeutics. The round was announced on 2/18/2025.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

6000 Shoreline Drive, Suite 206
South San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.perceivebio.com

Email Address

[email protected]

Overview

Exclusivity to decades of academic research elucidating two of the strongest protective biologies in retinal degeneration. Novel therapeutics to prevent the largest causes of irreversible blindness preparing for clinic with lead programs in dry AMD & neuroprotection. Team with exceptional insight & highly successful track record translating science through clinical development into strategic value.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

K. Angela Macfarlane

        

Browse more venture capital transactions:

Prev: 2/18/2025: Quokka Care venture capital transaction
Next: 2/18/2025: Augmetec venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to record tech company VC transactions. All VC database entries reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary